| Literature DB >> 35206270 |
Kira Taux1, Thomas Kraus1, Andrea Kaifie1.
Abstract
Gold is one of the most valuable materials but is frequently extracted under circumstances that are hazardous to artisanal and small-scale gold miners' health. A common gold extraction method uses liquid mercury, leading to a high exposure in workers. Therefore, a systematic review according to the PRISMA criteria was conducted in order to examine the health effects of occupational mercury exposure. Researching the databases PubMed®, EMBASE® and Web of ScienceTM yielded in a total of 10,589 results, which were screened by two independent reviewers. We included 19 studies in this review. According to the quantitative assessment, occupational mercury exposure may cause a great variety of signs and symptoms, in particular in the field of neuro-psychological disorders, such as ataxia, tremor or memory problems. However, many reported symptoms were largely unspecific, such as hair loss or pain. Most of the included studies had a low methodological quality with an overall high risk of bias rating. The results demonstrate that occupational mercury exposure seriously affects miners' health and well-being.Entities:
Keywords: disease; health; heavy metal; intoxication; neuro-psychological disorders; work
Mesh:
Substances:
Year: 2022 PMID: 35206270 PMCID: PMC8871667 DOI: 10.3390/ijerph19042081
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 3.390
Inclusion and Exclusion Criteria.
| PECO Scheme | Inclusion Criteria | Exclusion Criteria |
|---|---|---|
| Population | Workers (adults as well as children and adolescents under the age of 18 years) with an ongoing occupation as gold miner in middle- and low-income countries | Adults as well as children and adolescents under the age of 18 years with no activity in gold mining; gold miners who interrupted their gold mining activities; former gold miners; residents; workers from high income countries |
| Exposure | Ongoing direct occupational-related mercury exposure; use of the amalgamation method for gold extraction | No ongoing direct occupational-related mercury exposure; use of other methods for gold extraction (e.g., cyanide) |
| Comparison | Adults as well as children and adolescents under the age of 18 years with no direct gold mining activities; residents | Workers (children and adolescents under the age of 18 years and adults) with direct relation to gold mining activities; former gold miners |
| Outcome | Primary outcome: | Studies that do not match the inclusion criteria |
Figure 1Flow chart of literature research and screening process.
Data extraction.
| Author, Year | Study Design, Setting, Time, Participants, Exposure | Measurements, Examinations | Outcome | Effect Parameters (Bold Indicates Statistically Significance) |
|---|---|---|---|---|
| Afrifa et al. (2017) [ | cross-sectional study exposed (B–Hg ≥ 5.0 µg/L): n = 61 (mean age 35.8 years, mean work duration 14.7 years) non-exposed (B–Hg < 5.0 µg/L): n = 49 (mean age 34 years, mean work duration 10.8 years) | B–Hg (mean 18.4 µg/L) urine protein (mean 41.7 mg/dL) serum creatinine (mean 2.2 µmol/L) non-significant more frequent in exposed: skin rash, cough, fever, itchy eyes, fatigue, headache, muscle ache, numbness, hair loss non-significant less frequent in exposed: metallic taste | significantly positive: proteinuria significantly negative: eGFR urine protein ≥ 10 mg/dL: OR = serum creatinine > 106 µmol/L: OR = eGFR ≤ 90 mL/min/1.73 m2: OR = neuro-psychological symptoms: fatigue (OR = 1.1 (0.5–2.6)), headache (1.3 (0.5–3)), numbness (OR = 1.9 (0.9–4.1)) other symptoms: skin rash (OR = 1.4 (0.7–3)), cough (OR = 1.7 (0.8–3.6)), fever (OR = 1.1 (0.5–2.4)), itchy eyes (OR = 1.2 (0.5–2.9)), muscle ache (OR = 1.5 (0.7–3.2)), hair loss (OR = 1.2 (0.2–7.6)), metallic taste (OR = 0.7 (0.3–1.5)) | |
| Afrifa et al. (2018) [ | cross-sectional study exposed (B–Hg ≥ 5.0 µg/L): n = 80 (median age 26 years, median work duration 8 years) non-exposed (B–Hg < 5.0 µg/L): n = 57 (median age 30 years, median work duration 4 years) | thyroid hormones: T4, T3, TSH Hg | significantly elevated levels: B–Hg (median 8 µg/L) significantly reduced levels:
T4 (mean 5.4 µg/dl) T3 (mean 1.5 nmol/L) non-significantly elevated levels: TSH (mean 1.7 mIU/L) | significantly negative: T4 non-significantly positive: TSH (r = 0.1) |
| Rajaee et al. (2015) [ | cross-sectional study Kejetia (miners + residents) Gorogo (controls) | pulse blood pressure: SBP, DBP, MAP, PP | non-significantly positive: PP (ß = 1.9), SBP (ß = 1.4), MAP (ß = 0.1) non-significantly negative: DBP (ß = −0.5), pulse (ß = −0.3) non-significantly positive: PP (ß = 0.2), SBP (ß = 0.1) non-significantly negative: DBP (ß = −0.1), pulse (ß = −0.02), MAP (ß = −0.04) | |
| Mensah et al. (2016) [ | cross-sectional study exposure: exposed (U–Hg ≥ 5.0 µg/L): n = 160 non-exposed (U–Hg < 5.0 µg/L): n = 183 workplace (previous occupation in another mine): n = 25 | neuro-psychological symptoms: headache (χ2 = 0.7), fatigue (χ2 = 0.01), insomnia (χ2 = 1), numbness (χ2 = 0.00) other symptoms: red eyes (χ2 = 0.3), skin rash (χ2 = 3.5), cough (χ2 = 0.2), fever (χ2 = 0.1), metallic taste (χ2 = 0.4), muscle ache (χ2 = 0.1), sinusitis (χ2 = 0.4), hair loss (χ2 = 0.04) | ||
| Bose-O’Reilly et al. (2010a) [ | cross-sectional study Rwamagasa/Geita District Katoro non-smelters: n = 34 (n = 20 male, n = 14 female, age 14–50 years, mean age 26.6 years) smelters: n = 104 (n = 87 male, n = 17 female, age 14–57 years, mean age 33.8 years) | U–Hg: non-smelters 1 µg/L (0.8 µg/gCr), smelters 5.9 µg/L (3.6 µg/gCr) B–Hg: non-smelters 1.6 µg/L, smelters 2.5 µg/L hair: T–Hg: non-smelters 0.5 µg/g, smelters 0.8 µg/g I–Hg: non-smelters 0.1 µg/g, smelters 0.4 µg/g worsened health neuro-psychological symptoms: memory problems, tiredness, tremor finger-to-nose + eyelid, sadness, problems to find words, ataxia of gait, sensory disturbance, abnormal ASR + BSR other symptoms: less appetite, salivation, discoloured gum neuro-psychological symptoms: sleep problems, concentration problems, thinking problems, nervousness, headache, numbness, problems with impetus, dysdiadochokinesia, intentional tremor heel-to-shin, ataxia heel-to-shin, bradykinesia, hypomimia, abnormal PSR other symptoms: loss of hair, metallic taste, less muscle strength, weakness, eyestrain problems, palpitations, nausea, stomatitis, gingivitis significantly worse results in exposed: pencil tapping test, matchbox test no significant differences: memory test, Frostig score |
neuro-psychological symptoms: sleep problems (OR = 1.2 (0.6–2.5)), tremor (OR = 3.1 (0.9–10.9)), nervousness (OR = 1.2 (0.5–2.9)), sadness (OR = 1.9 (0.9–3.7)), headache (OR = 1.3 (0.7–2.4)), numbness (OR = 1.1 (0.6–2.1)) other symptoms: loss of appetite (OR = 1.7 (0.8–3.6)), hair loss (OR = 2.7 (0.1–53.4)), metallic taste (OR = 1.1 (0.2–5.8)), salivation (OR = 2.5 (1–6.4)), palpitations (OR = 1.4 (0.7–2.7)), nausea (OR = 1.1 (0.5–2.4)) | |
| Harada et al. (1999) [ | cross-sectional study seven gold mines near Lake Victoria one gold mine in the inland three fishing villages around Lake Victoria one fishing village in the inland Mwanza/State of Mwanza | mean T–Hg 1–81.9 ppm mean T–Hg 1–4 ppm (exclusion of six cases >50 ppm) neuro-psychological symptoms (trembling 21.2%, headache 11.9%, numbness 9.3%, sensory disturbance 8.5%, taste problems 8.5%, tremor 8.5%, abnormal reflex 5.1%/2.5%, memory problems 7.6%, smell problems 5.9%, insomnia 5.1%, vertigo/dizziness 5.1%, neurasthenia 3.4%, night blindness 3.4%) pain (chest pain 8.5%, limb pain 5.9%) respiratory problems (dyspnoea 7.6%, cough 6.8%) other symptoms: palpitation (5.9%), gingivitis (13.6%) mild I–Hg intoxication: n = 14 | – | |
| Bose-O’Reilly et al. (2008) [ | cross-sectional study | B–Hg: median 7.8 µg/L U–Hg: median 10.1 µg/L, 7.1 µg/gCr hair:
T–Hg: median 2.3 µg/g I–Hg: median 0.9 µg/g neuro-psychological symptoms (ataxia, dysdiadochokinesia, abnormal reflexes) other symptoms: salivation, metallic taste, blue coloration of gums neuro-psychological symptoms (headache, memory problems, nausea, numbness/prickling feet, concentration problems, sleeping problems, tremor, hypomimia, mento-labial reflex) other symptoms: gingivitis, stomatitis, proteinuria significantly worse performance in miners + residents: matchbox test, pencil tapping test no significant difference: memory test, Frostig score | ataxia: heel-to-shin abnormal reflex: mento-labial tremor (OR = 2 (0.2–19.3)): finger-to-nose (OR = 4.6 (0.2–90.2)), heel-to-shin (OR = 1.9 (0.1–47.7)), eyelid (OR = 1.5 (0.7–3)) | |
| Steckling et al. (2014) [ | cross-sectional study Kadoma (gold miners) Chikwaka (controls) | neuro-psychological symptoms: tremor at work + finger-to-nose, ataxia of gait, dysdiadochokinesia other symptoms: metallic taste, blue discoloured gum worse results in neuro-psychological tests: Frostig test, pencil tapping test worsened health neuro-psychological symptoms: heel-to-knee ataxia, heel-to-knee-tremor, abnormal reflex, sleeping problems other symptoms: salivation, proteinuria worse results in neuro-psychological tests: memory test, matchbox test most affected: male (78,400 DALYs, 13 DALYs/1000 persons) female (17,000 DALYs, 3 DALYs/1000 persons) | – | |
| Tayrab (2017) [ | cross-sectional study Abuhamad gold mining area/River Nile State (gold miners) Khartoum State (controls) | significantly elevated levels in miners: TSH (mean 5.1 µIU/mL) TT4 (mean 86.3 pmol/L) TT3 (mean 1.2 ng/dL) FT3 (mean 1.3 pg/mL) FT4 (mean 6.4 ng/dL) | – | |
| Tomicic et al. (2011) [ | cross-sectional study Bagassi Bouda Fandjora II + III Mossobadougou Pousghin (Macara) Safané Zinigma most susceptible to Hg: n = 93 (n = 82 male, n = 11 female, age 17–56 years, mean age 31.7 years, occupational Hg exposure 1–12 years, mean occupational Hg exposure 4 years) gold dealers: n = 146 (susceptible: n = 52) ore washers: n = 151 (susceptible: n = 33) others (susceptible: n = 8) | 69% >35 µg/gCr, 16% >350 µg/gCr (reference < 3 µg/gCr) statistically significant trend: dealers > ore washers > others walking problems (8.2%) rhinitis (9.5%) neuro-psychological symptoms (headache 53.3%, sleep problems 25.3%, dizziness 53.8%, tiredness 33%, trembling 31.9%, sensory problems on hands/feet 23.1%, visual problems 30.8%) other symptoms: mouth irritations/wounds (22%), cough (27.5%), thoracic pain (34.1%) | ore washing + trembling: packaging Hg + rhinitis: U–Hg:
thoracic pain: grabbing problems: gold dealer + trembling: χ2 3.7 heating Hg + thoracic pain: χ2 3.5 | |
| Wanyana et al. (2020) [ | cross-sectional study Amudat/Karamoja Region Busia/Eastern Region Ibanda/Western Region Mubende/Central Region extractors processors burners/buyers | significantly higher: Mubende, OHS knowledge significantly higher: Mubende, female, panners, OHS knowledge drinking water: mean 23.8 µg/L (in all samples above WHO limit (6 µg/L)) soil: mean 0.2 µg/L least in Ibanda statistically significant more frequent:
female: swollen legs, psychiatric problems, stomachache, memory problems, diarrhoea, respiratory problems male: headache no significant differences between male + female: injuries, numbness, shaking hands, pain (back, chest, joint, feet), eye problems, general malaise, dizziness, fatigue + stress | shaking of hands + head: eye problems: numbness: fatigue + stress: headache: dizziness: chest: back: joint: | |
| Bose-O’Reilly et al. (2010b) [ | cross-sectional study Tatelu in North Sulawesi Kerang Pangi in Central Kalimantan non-smelters: n = 47 (n = 31 female, n = 16 male, age 19–59 years, mean age 33.7 years for Kalimantan/36 years for Sulawesi) smelters: n = 129 (n = 28 female, n = 101 male, age 19–58 years, mean age 31.9 years for Kalimantan/35.2 years for Sulawesi) | U–Hg: non-smelter 5.3–7.8 µg/L (3.3–3.7 µg/gCr), smelter 10.2–22.4 µg/L (5.3–10.2 µg/gCr) B–Hg: non-smelter 9.2–9.5 µg/L, smelter 10.6–13.3 µg/L hair: T–Hg: non-smelter 3–3.8 µg/g, smelter 3.9–4.9 µg/g I–Hg: non-smelter 1.1–1.2 µg/g, smelter 1.3–2 µg/g neuro-psychological symptoms (ataxia of gait + heel-to-shin, eyelid tremor, hypomimia) Central Kalimantan: hair loss, salivation, numbness, fatigue North Sulawesi: sleeping problems, fatigue (for smelters) significantly worse results: memory test, pencil tapping test, matchbox test non-significantly worse results: Frostig score smelters: n = 33 (Sulawesi), n = 43 (Kalimantan) non-smelters: n = 4 (Sulawesi), n = 13 (Kalimantan) residents: n = 3 (Sulawesi), n = 21 (Kalimantan) | Kalimantan: Sulawesi: | |
| Ekawanti and Krisnayanti (2015) [ | cross-sectional study | significantly elevated levels in miners:
urine protein (mean 1.7 g/L) U–Hg (mean 69.4 µg/L) more frequent in miners: proteinuria (92.6%) significantly reduced in miners:
haemoglobin (mean 12.7 g/dL) haematocrit (mean 38.2%) more frequent in miners: anaemia (57.7% for standard limits, 67.6% for smokers’ limits) | – | |
|
| cross-sectional study Astor Dainyor Gulmiti Gupis Haramosh Ishkumen Jaglot Jalalabad Jutal Khari Shimshal | RBC plasma | adults: male 57.1 µg/L, female 68.5 µg/L (98% exceed WHO limit (50 µg/L)) children: male 24.5 µg/L, female 13.6 µg/L | – |
| Riaz et al. (2016) [ | cross-sectional study Chalt Chirmish Goharabad Jalalabad Khari Minor Khari Nomal Yashokaldas | plasma: T–Hg, I–Hg, O–Hg RBC: T–Hg, I–Hg, O–Hg | T–Hg: male 61.4 µg/L, female 51.7 µg/L I–Hg: male 40.5 µg/L, female 36.5 µg/L | – |
|
| cross-sectional study | riverines: all below reference, significantly smaller perimetric area than miners miners: 61.8% below reference miners: significantly more errors than controls, no significant difference to riverines | visual perimetry: partial r = 0.1 colour vision: partial r = 0.5 | |
| Branches et al. (1993) [ | case series Tapajós/Pará region Tapajós/Amazonas region gold shop workers (n = 11, male, mean age 37 years, mean occupational Hg exposure 5.3 years) gold miners (n = 22, male, mean age 43 years, mean occupational Hg exposure 16.3 years) | neuro-psychological symptoms (dizziness 45%, headache 45%, tremor 45%/9%, insomnia 41%, numbness 41%, visual problems 41%/18%, memory problems 32%, nervousness 23%, balance problems 18%/14%, coordination problems 18%, fatigue 18%, seagull sign 18%, cramps 14%, fear 14%, ataxia 5%, deep sensibility problems 5%, tactile problems 5%) pain (chest pain 27%, abdominal pain 14%) other symptoms: palpitations (36%), dyspnoea (27%), oedema (27%/18%), hair loss (27%/5%), hepatomegaly (27%) + splenomegaly (23%) (positive anamnesis for malaria), loss of appetite (27%), impotence (23%), weakness (23%), weight loss (23%), tonsillar hypotrophy (18%), no physical pathologies (14%), premature aging (14%), pruritus (5%), gingivitis (5%) |
neuro-psychological symptoms: dizziness (OR = 0.8 (0.3–2.7)), headache (OR = 1.2 (0.5–2.9)), tremor (OR = 1.8 (0.5–6.1)), numbness (OR = 1.5 (0.5–4.7)), insomnia (OR = 1.9 (0.5–6.6)), nervousness (OR = 0.3 (0.1–1.1)), visual problems (OR = 4.4 (1–19.4)), memory problems (OR = 2.1 (0.5–8.6)), cramps (OR = 0.7 (0.1–3.6)), fatigue (OR = 1.4 (0.3–7.2)), fear (OR = 0.7 (0.1–3.6)) pain: chest (OR = 3.6 (0.7–21.2)), abdomen (OR = 1 (0.2–5.6)) other symptoms: palpitations (OR = 0.5 (0.1–1.6)), dyspnoea (OR = 1 (0.3–3.8)), loss of appetite (OR = 1 (0.3–3.8)), weakness (OR = 0.5 (0.1–1.9)), hair loss (OR = 2.4 (0.5–11.1)), pruritus (OR = 0.5 (0–5.7)), impotence (OR = 14.1 (0.7–273.4)), weight loss (OR = 2.9 (0.5–17.1)), oedema (OR = 7.9 (0.9–72.1)) | |
| Harari et al. (2012) [ | cross-sectional study | 11% miners + 71.4% merchants exceed BEI limit (>15 µg/L) miners: 0.7–100 µg/L (mean 5.3 µg/L) 5.1% miners + 61.1% merchants exceed BEI limit (>35 µg/L) miners: 0.3–170 µg/gCr (mean 3.3 µg/gCr) | B–Hg:
tremor (centre frequency left) reaction time U–Hg:
tremor (centre frequency) reaction time B–Hg: postural sway (velocity) U–Hg: postural sway (velocity) | |
| Schutzmeier et al. (2016) [ | cross-sectional study Portovelo Zaruma | <0.5–163 µg/L (median 1.8 µg/L) 78.3% < HMB-I (7 µg/L), 15.8% 7–25 µg/L, 5.9% >HBM-II (25 µg/L), 3.4% >BAT (35 µg/L) neuro-psychological symptoms (sleeping problems 91.7%, dysdiadochokinesia 88.9%, ataxia of gait 72.2%, tremor 13.9%) problems in neuro-psychological tests (matchbox test 91.7%, heel-to-shin test 88.9%, pencil tapping test 75%) other symptoms: discoloured gum 33.3%, salivation 33.3%, proteinuria 2.8% |
Bias assessment. (XS: cross sectional study).
| Study | Study Design | Internal Validity—Bias | Internal Validity—Confounder (Selection Bias) | Performance Bias | Detection Bias | Attrition Bias | Reporting Bias | Others |
|---|---|---|---|---|---|---|---|---|
| Afrifa et al. (2017) [ | XS | low risk | low risk | low risk | low risk | low risk | low risk | contradictory data (The text (page 6) reports a different odds ratio for serum creatinine than the corresponding table (page 7).) |
| Afrifa et al. (2018) [ | XS | low risk | low risk | low risk | low risk | high risk | low risk | none |
| Rajaee et al. (2015) [ | XS | high risk | low risk | low risk | high risk | high risk | low risk | none |
| Mensah et al. (2016) [ | XS | high risk | high risk | low risk | low risk | low risk | low risk | none |
| Bose-O’Reilly et al. (2010a) [ | XS | low risk | low risk | low risk | low risk | low risk | low risk | none |
| Harada et al. (1999) [ | XS | high risk | high risk | low risk | high risk | high risk | low risk | (1) H–Hg as general marker for Hg exposure |
| Bose-O’Reilly et al. (2008) [ | XS | low risk | low risk | low risk | low risk | low risk | low risk | none |
| Steckling et al. (2014) [ | XS | low risk | high risk | low risk | high risk | low risk | low risk | only the study in Zimbabwe could be taken into account |
| Tayrab (2017) [ | XS | high risk | high risk | low risk | low risk | high risk | low risk | none |
| Tomicic et al. (2011) [ | XS | high risk | high risk | low risk | high risk | high risk | low risk | none |
| Wanyana et al. (2020) [ | XS | low risk | low risk | low risk | high risk | low risk | low risk | contradictory data (The text says that 75.8% of the miners use PPE (page 5), while the table says that 75.8% of the miners do not use PPE ( |
| Bose-O’Reilly et al. (2010b) [ | XS | low risk | low risk | low risk | low risk | low risk | low risk | none |
| Ekawanti and Krisnayanti (2015) [ | XS | high risk | high risk | low risk | high risk | high risk | low risk | no detailed information about child labour in the control group |
| Khan et al. (2012) [ | XS | high risk | high risk | low risk | high risk | high risk | low risk | (1) contradictory data (The text (page 2) gives the concentrations of T–Hg in RBC and plasma for children, who work as miners, in another order than the table ( |
| Riaz et al. (2016) [ | XS | high risk | high risk | low risk | low risk | high risk | low risk | contradictory data (The text says that the values of T–Hg in hair are higher for female miners, although this is—according to the reported data—not the case.) |
| Lacerda et al. (2020) [ | XS | high risk | low risk | low risk | high risk | high risk | low risk | (1) H–Hg as general marker for Hg exposure |
| Branches et al. (1993) [ | Case series | high risk | high risk | low risk | high risk | high risk | low risk | contradictory data (The number of urban inhabitants differs in the text (n = 21 on page 4, n = 22 on page 8).) |
| Harari et al. (2012) [ | XS | high risk | high risk | low risk | low risk | low risk | low risk | none |
| Schutzmeier et al. (2016) [ | XS | low risk | low risk | low risk | high risk | low risk | low risk | none |